- Promote the dissemination of hydroxyurea, a drug that significantly reduces painful attacks, hospitalisations and mortality related to sickle cell disease, at minimal cost in Africa
- Promote the dissemination of other drugs that alleviate the suffering of patients

Recommandation hydroxyurée 2025 en Afrique